Mumbai’s fight against tuberculosis (TB) may be entering a new phase, with the Brihanmumbai Municipal Corporation (BMC) considering a pilot project to utilize tongue swabs for quicker and easier TB detection. This potential shift comes on the heels of new recommendations from the World Health Organization (WHO) advocating for the use of innovative testing methods in countries with a high TB burden, like India. The current standard for TB diagnosis relies on collecting sputum – mucus coughed up from deep within the lungs – a process that can be challenging for some patients, particularly children.
The prospect of using tongue swabs, which collect saliva and fluid from the tongue, offers a less invasive alternative. “Collecting tongue swabs would be easier for some patients, especially children,” explained Dr. Daksha Shah, BMC’s executive health officer. Whereas still in the early planning stages, the BMC has a history of embracing new technologies to improve TB detection, previously piloting the use of artificial intelligence (AI) to analyze X-ray scans for signs of the disease.
Mumbai faces a significant TB challenge, historically identified as a high-density hub for the disease. The emergence of drug-resistant strains in 2011-12 prompted the launch of a special National TB programme focused on accelerating access to new tests and treatments. While the city registered 65,435 TB cases in 2022, numbers have been declining, with 54,390 cases reported in the following year. However, drug-resistant TB remains a concern, accounting for 8% of those cases. The WHO’s February 26th recommendations aim to address these challenges by expanding access to testing through near-point-of-care (NPOC) molecular tests, including those utilizing tongue swab samples.
The Promise of Faster, More Accessible Testing
The new WHO policy represents a significant step forward in TB diagnosis, according to Dr. Madhukar Pai, a Canada-based epidemiologist and public health expert. “This new WHO policy is a big deal in the world of TB,” Dr. Pai stated. “For the first time, it has approved a near point-of-care molecular test that can be used at the primary care level, and also with a tongue swab since many people are unable to produce a sputum.” The tests are available through the Global Drug Facility at a cost of $3.5 per test, making them considerably more affordable than previous molecular testing options.
Several Indian companies are already positioned to provide these tests. Huwel and Molbio Diagnostics are specifically named as having products that align with the WHO’s new guidelines. Shiva Sriram, president of Goa-based Molbio Diagnostics, confirmed that their Truenat platform, already deployed in primary health centers across India, is capable of processing multiple sample types, including tongue swabs. Molbio’s Truenat platform has been instrumental in expanding TB testing access in remote areas.
Challenges and Considerations
Despite the potential benefits, tongue swab-based testing is still considered an emerging approach. Sriram cautioned that there is currently limited field data available to fully assess its effectiveness. “As programmatic adoption increases, it is expected to generate stronger evidence and inform scaled implementation,” he said. The accuracy and reliability of tongue swabs compared to traditional sputum tests will be crucial factors in determining the success of any pilot program.
The shift towards easier testing methods is particularly important in a city like Mumbai, where identifying and treating TB cases quickly is vital to preventing further spread. Early detection is key to curbing the development of drug-resistant strains, which pose a significant threat to public health. The BMC’s previous pilot project utilizing AI for X-ray analysis demonstrates its commitment to leveraging technology to combat TB. That initiative aimed to improve the speed and accuracy of initial screenings, allowing healthcare workers to focus resources on patients most likely to have the disease.
What the Pilot Project Could Entail
While details of the proposed pilot project are still being finalized, it is likely to involve a phased rollout, starting with select healthcare facilities in Mumbai. Researchers will compare the results of TB tests performed using tongue swabs with those obtained from traditional sputum samples. Factors such as test sensitivity, specificity, and patient acceptance will be carefully evaluated. The pilot project will also assess the feasibility of integrating tongue swab testing into existing TB control programs.
The success of the pilot will depend on several factors, including the availability of trained personnel, the reliability of the testing equipment, and the willingness of patients to participate. Effective communication and community engagement will be essential to ensure that the pilot project reaches those who need it most. The BMC will likely collaborate with local NGOs and community health workers to raise awareness about the new testing method and encourage participation.
The potential benefits of widespread adoption of tongue swab testing extend beyond Mumbai. If the pilot project proves successful, it could pave the way for similar initiatives in other high-TB-burden cities across India and around the world. This could significantly improve TB detection rates, reduce the spread of the disease, and ultimately save lives.
The BMC is expected to announce further details about the pilot project, including the timeline and participating facilities, in the coming weeks. This initiative represents a promising step towards a more accessible and effective TB control strategy for Mumbai and beyond. The next step will be the formal launch of the pilot program and the subsequent analysis of the collected data.
Have your say: What are your thoughts on the potential of tongue swab testing for TB detection? Share your comments below and help us continue the conversation.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
